Folgen
Burcu AKMAN, PhD
Burcu AKMAN, PhD
Izmir Biomedicine and Genome Center (iBG)
Bestätigte E-Mail-Adresse bei ibg.edu.tr
Titel
Zitiert von
Zitiert von
Jahr
Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1
E Baytak, Q Gong, B Akman, H Yuan, WC Chan, C Küçük
Tumor Biology 39 (5), 1010428317701648, 2017
402017
Plasma concentrations and cancer-associated mutations in cell-free circulating DNA of treatment-naive follicular lymphoma for improved non-invasive diagnosis and prognosis
T Hatipoğlu, E Esmeray Sönmez, X Hu, H Yuan, A Erşen Danyeli, ...
Frontiers in Oncology, 2395, 2022
102022
Human Leukocyte Antigen Class I-II Allele Frequencies and Association Between Human Leukocyte Antigen Alleles and ABO Blood Group Antigens
M Soyoz, B Akman, I Totur, S Topcu, AO Kocyigit, BC Gurbuz, C Yuksel, ...
TURKISH JOURNAL OF IMMUNOLOGY 4 (1), 14-18, 2016
92016
The relationship of rel proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma
X Hu, E Baytak, J Li, B Akman, K Okay, G Hu, A Scuto, W Zhang, C Küçük
Leukemia research 54, 30-38, 2017
72017
PRDM1 decreases sensitivity of human NK cells to IL2‐induced cell expansion by directly repressing CD25 (IL2RA)
B Akman, X Hu, X Liu, T Hatipoğlu, H You, WC Chan, C Küçük
Journal of Leukocyte Biology, 2020
52020
Flow cytometric evaluation of T and B lymphocyte percentage in chronic kidney disease
TK Ayna, B Akman, AÖ Koçyiğit, D Güleç, C Tugmen, M Soyöz
Medical Research Journal 2 (1), 29-33, 2017
42017
Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma
E Esmeray Sönmez, T Hatipoğlu, D Kurşun, X Hu, B Akman, H Yuan, ...
Cells 11 (21), 3394, 2022
22022
Implications of Chromatin Modifier Mutations in Epigenetic Regulation of Bladder Cancer
B Akman, SE Özhan
Exon Publications, 2022
22022
Ultra-Deep Targeted Sequencing Reveals Cancer-Associated, Prognostically Significant Mutations in Circulating Cell-Free DNA in Treatment-Naive Patients with Follicular Lymphoma
T Hatipoglu, E Esmeray, X Hu, H Yuan, AE Danyeli, A Seyhanli, TO Suzek, ...
BLOOD 136, 2020
12020
The Effect of Panel Reactive Antibody Results on Graft Functions of Patients with Chronic Kidney Failure
AU İbrahim Pirim, Tülay Kılıçaslan Ayna, Derya Güleç, Mustafa Soyoz, Aslı ...
Turkish Journal of Immunology, 2015
12015
Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells
G Ozgun, T Yaras, B Akman, G Özden-Yılmaz, N Landman, G Karakülah, ...
Cancer Gene Therapy, 1-15, 2024
2024
Genetic and Epigenetic Analyses Reveal Transcriptional Silencing of SOX7 due to Deletion in a Multiple Myeloma Case with Double Relapse
A SEYHANLI, T HATIPOGLU, B AKMAN, HU Xiaozhou, GH OZSAN, ...
International Journal of Hematology and Oncology 33 (1), 054-056, 2023
2023
CD25 (IL2RA) Is a Direct Transcriptional Target of PRDM1 in Activated Human Natural Killer Cells
B Akman, D Kursun, T Hatipoglu, X Hu, WC Chan, C Kucuk
Blood 132 (Suppl 1), 3724-3724, 2018
2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–13